Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,568
Closed -$249K 1800
2022
Q3
$249K Sell
2,568
-3,049
-54% -$364K ﹤0.01% 1422
2022
Q2
$591K Buy
5,617
+2,397
+74% +$306K 0.01% 895
2022
Q1
$555K Buy
+3,220
New +$481K 0.01% 1006

Other funds holding AMED

Atria Wealth Solutions's AMED Position: Q4 2022 in Review

Atria Wealth Solutions sold out of Amedisys (AMED) in Q4 2022, closing a stake of 2,568 shares — an estimated $249K sold.

Atria Wealth Solutions first reported a position in AMED in Q1 2022 and held it in 3 quarters. The position peaked at $591K in Q2 2022. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Atria Wealth Solutions reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Atria Wealth Solutions sold 2,568 Amedisys shares in Q4 2022, an estimated $249K.
  • Atria Wealth Solutions first reported a position in Amedisys in Q1 2022 and held it in 3 quarters.
  • Atria Wealth Solutions's Amedisys position peaked at $591K in Q2 2022.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Atria Wealth Solutions's 13F filing for Q4 2022, filed 13 Feb 2023.